Researchers have found a potential link between vitamin D deficiency and a higher rate of hospitalization for respiratory ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-DIMER-PA, the company’s investigational RNA interference (RNAi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results